Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of GSP 301 nasal spray versus Patanase and Nasonex in Chinese patients with seasonal allergic rhinitis
ChiCTR2200058442Phase 3Recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of olopatadine + mometasone, olopatadine and mometasone in seasonal allergic rhinitis (SAR), sponsored by Beijing Tongren Hospital. Started Oct 2021; status: recruiting.
02
Drugs
olopatadine + mometasoneolopatadinemometasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on ChiCTR2200058442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058442.